ProPhase Labs Market Cap

ProPhase Labs has a market cap or net worth of $90.31 million as of April 25, 2024. Its market cap has decreased by -32.61% in one year.

Market Cap

90.31M

Enterprise Value

107.41M

1-Year Change

-32.61%

Ranking

#4187

Market Cap Chart

Since December 1, 1998, ProPhase Labs's market cap has decreased from $92.00M to $90.31M, a decrease of -1.84%. That is a compound annual growth rate of -0.07%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2024	93.10M	5.32%
Apr 22, 2024	88.40M	-6.85%
Apr 19, 2024	94.90M	-3.36%
Apr 18, 2024	98.20M	-13.17%
Apr 17, 2024	113.10M	-14.71%
Apr 16, 2024	132.60M	19.35%
Apr 15, 2024	111.10M	-5.61%
Apr 12, 2024	117.70M	1.90%
Apr 11, 2024	115.50M	4.43%
Apr 10, 2024	110.60M	0.45%
Apr 9, 2024	110.10M	-7.56%
Apr 8, 2024	119.10M	-2.93%
Apr 5, 2024	122.70M	3.37%
Apr 4, 2024	118.70M	-0.67%
Apr 3, 2024	119.50M	-3.86%
Apr 2, 2024	124.30M	0.57%
Apr 1, 2024	123.60M	5.82%
Mar 28, 2024	116.80M	3.36%
Mar 27, 2024	113.00M	-0.44%
Mar 26, 2024	113.50M	1.43%
Mar 25, 2024	111.90M	6.17%
Mar 22, 2024	105.40M	3.94%
Mar 21, 2024	101.40M	1.60%
Mar 20, 2024	99.80M	5.72%
Mar 19, 2024	94.40M	1.72%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly	706.88B
Novo Nordisk	565.69B
UnitedHealth Group	449.55B
Johnson & Johnson	362.21B
Merck & Co.	321.70B
AbbVie	301.19B
AstraZeneca	220.03B
Thermo Fisher	219.59B

Market Cap Rankings